Evidence map›Paper›PMID 29577833›Full record

ArticleAmerican journal of men's health2018

Association Between Nonalcoholic Fatty Liver Disease and Severe Male Reproductive Organ Impairment (Germinal Epithelial Loss): Study on a Mouse Model and on Human Patients.

Uriel A López-Lemus, Raquel Garza-Guajardo, Oralia Barboza-Quintana, Alejandrina Rodríguez-Hernandez, Alejandro García-Rivera, Violeta M Madrigal-Pérez, José Guzmán-Esquivel, Laura E García-Labastida, Alejandro D Soriano-Hernández, Margarita L Martínez-Fierro and 5 more

Abstract readComparative Study
In one paragraph

Article in American journal of men's health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Uriel A López-Lemus1 School of Medicine, University of Colima, Colima, Mexico.
Raquel Garza-Guajardo2 Department of Pathological Anatomy and Cytopathology, University Hospital "Dr José Eleuterio González," Autonomous University of Nuevo León, Monterrey, Nuevo León, Mexico.
Oralia Barboza-Quintana2 Department of Pathological Anatomy and Cytopathology, University Hospital "Dr José Eleuterio González," Autonomous University of Nuevo León, Monterrey, Nuevo León, Mexico.
Alejandrina Rodríguez-Hernandez1 School of Medicine, University of Colima, Colima, Mexico.
Alejandro García-Rivera1 School of Medicine, University of Colima, Colima, Mexico.
Violeta M Madrigal-Pérez1 School of Medicine, University of Colima, Colima, Mexico.
José Guzmán-Esquivel3 Unidad de Investigación del Hospital General de Zona Nº 1. IMSS, Colima, Mexico.
Laura E García-Labastida2 Department of Pathological Anatomy and Cytopathology, University Hospital "Dr José Eleuterio González," Autonomous University of Nuevo León, Monterrey, Nuevo León, Mexico.
Alejandro D Soriano-Hernández4 Cancerology State Institute, Colima State Health Services, Colima, Mexico.
Margarita L Martínez-Fierro5 Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences. Universidad Autónoma de Zacatecas, Zacatecas, Mexico.
Iram P Rodríguez-Sánchez6 School of Biological Sciences. Autonomous University of Nuevo León, Nuevo León, Mexico.
Elizabeth Sánchez-Duarte7 Department of Applied Sciences, University of Guanajuato, León, Guanajuato, Mexico.
Ariana Cabrera-Licona4 Cancerology State Institute, Colima State Health Services, Colima, Mexico.
Gabriel Ceja-Espiritu1 School of Medicine, University of Colima, Colima, Mexico.
Iván Delgado-Enciso1 School of Medicine, University of Colima, Colima, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MS) has been associated with testicular damage. Nonalcoholic fatty liver disease (NAFLD) is a multisystemic disease that affects different organs, but its effect on the testes is unknown. A study analyzing germ cell involvement on BALB/c mice was carried out. A parallel comparative study was conducted that investigated alterations in the germinal epithelium of male humans that died from an unrelated acute event. The complete medical histories and histologic samples of the thoracic aorta, liver tissue, and testicular tissue from the deceased subjects were collected. The degree of germinal epithelial loss (DGEL) was evaluated and the clinical and histologic data were compared between individuals with and without NAFLD. The only metabolic or morphologic variable that caused a significant difference in the DGEL, in both the animal model and humans, was the presence of liver steatosis. The percentage of steatosis was also correlated with the percentage of the DGEL. In humans, steatosis (greater than 20%) increased the risk 12-fold for presenting with a severe DGEL (OR: 12.5; 95% CI [1.2, 128.9]; p = .03). There was no association with age above 50 years or MS components. Steatosis grade was also correlated with atherosclerosis grade. NAFLD was a strongly associated factor implicated in severe DGEL, as well as the testis was identified as a probable target organ for damage caused by the disease. This finding could result in the search for new approach strategies in the management of men with fertility problems. Further studies are required to confirm these results.

Indexed as

AdultAnimalsAtherosclerosisGerm CellsHumansMaleMetabolic SyndromeMiceMice, Inbred BALB CMiddle AgedModels, AnimalNon-alcoholic Fatty Liver DiseaseSeverity of Illness IndexTestisatherosclerosisgerm cellsmetabolic syndromesteatosistestis

Identifiers

PMID29577833
PMCPMC5987961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.